Beverly, MA, United States of America

Michael Manzo

This inventor holds 3 USPTO granted patents and 1 published patent application, plus 1 CIPO patent and 1 EPO patent. Top assignee: Eyegate Pharmaceuticals, Inc.. Active years: 2015-2018.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Michael Manzo. Retrieved from https://idiyas.com/inventor/michael-manzo

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 3 

% Patents Active = 33.3

 

 

Average Co-Inventor Count = 2.1

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2015-2018

Loading Chart...
Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: Michael Manzo: Innovator in Ocular Therapeutics

Introduction

Michael Manzo is a notable inventor based in Beverly, MA (US), recognized for his contributions to ocular therapeutics. He holds a total of 3 patents that focus on innovative solutions for delivering therapeutic substances to the eye.

Latest Patents

One of his latest patents is the Iontophoretic Contact Lens. This invention provides contact lenses designed for ocular iontophoretic therapy. The lenses include a reservoir for a charged therapeutic compound, a current source for delivering iontophoretic current, and a sensing circuit to maintain a selected pH range of the therapeutic composition. Additionally, alternate embodiments feature active, sacrificial electrodes that generate ions to facilitate the transport of the charged compound into ocular tissue.

Another significant patent is the System and Method for Ocular Iontophoresis with Buffering. This invention encompasses compositions, devices, and methods for delivering a therapeutic substance across the surface of the eyeball via iontophoresis. It includes a therapeutic media reservoir and a buffering system that regulates pH during the transfer of the therapeutic substance. The buffering system can consist of various media, including foam, gel, or membranes, arranged in multiple layers or concentric cylinders.

Career Highlights

Michael Manzo is currently associated with Eyegate Pharmaceuticals, Inc., where he continues to develop innovative solutions in the field of ocular therapeutics. His work has significantly advanced the methods of delivering therapeutic agents to the eye, enhancing treatment options for patients.

Collaborations

Throughout his career, Michael has collaborated with notable colleagues such as Peyman Moslemy and William Schubert. These partnerships have contributed to the development and refinement of his innovative technologies.

Conclusion

Michael Manzo's work in ocular therapeutics exemplifies the impact of innovation in medicine. His patents reflect a commitment to improving patient care through advanced technology.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…